Endurant Capital Management LP - PROTEOSTASIS THERAPEUTICS IN ownership

PROTEOSTASIS THERAPEUTICS IN's ticker is PTI and the CUSIP is 74373B109. A total of 52 filers reported holding PROTEOSTASIS THERAPEUTICS IN in Q4 2019. The put-call ratio across all filers is 0.67 and the average weighting 0.0%.

Quarter-by-quarter ownership
Endurant Capital Management LP ownership history of PROTEOSTASIS THERAPEUTICS IN
ValueSharesWeighting
Q4 2019$108,000
-34.5%
47,400
-63.7%
0.03%
-47.7%
Q1 2019$165,000
-92.6%
130,600
-72.3%
0.06%
-92.2%
Q1 2018$2,242,000
-20.7%
472,012
-2.7%
0.84%
-3.0%
Q4 2017$2,828,000485,0120.86%
Other shareholders
PROTEOSTASIS THERAPEUTICS IN shareholders Q4 2019
NameSharesValueWeighting ↓
VHCP Management III, LLC 848,610$2,749,0002.00%
GREAT POINT PARTNERS LLC 3,045,423$9,867,0001.25%
NEA Management Company, LLC 5,556,778$18,004,0000.71%
VHCP Management II, LLC 501,390$1,625,0000.70%
SECTORAL ASSET MANAGEMENT INC 1,581,728$5,125,0000.70%
HARBOURVEST PARTNERS LLC 440,627$1,428,0000.68%
EAM Investors, LLC 596,871$1,934,0000.52%
EAM Global Investors LLC 252,778$819,0000.45%
Avoro Capital Advisors LLC 1,300,000$4,212,0000.25%
Ghost Tree Capital, LLC 190,000$616,0000.22%
View complete list of PROTEOSTASIS THERAPEUTICS IN shareholders